Citation:

U.S. EPA. IRIS Toxicological Review of Hexahydro-1,3,5-Trinitro-1,3,5-Triazine (RDX) (Interagency Science Discussion Draft). U.S. Environmental Protection Agency, Washington, DC, EPA/635/R-18/065, 2018.

Impact/Purpose:

EPA is undertaking an update of the Integrated Risk Information System (IRIS) health assessment for Hexahydro-1,3,5-Trinitro-1,3,5-Triazine (RDX). The outcome of this project is an updated Toxicological Review and IRIS Summary that will be entered into the IRIS database.

Description:

In August 2018, EPA finalized the IRIS Toxicological Review of Hexahydro-1,3,5-Trinitro-1,3,5-Triazine (RDX). The Toxicological Review was reviewed internally by EPA and by other federal agencies and White House Offices in May 2018. Consistent with the May 2009 IRIS assessment development process, all written comments on IRIS assessments submitted by other federal agencies and White House Offices are made publicly available. Accordingly, interagency comments and the interagency science discussion materials provided to other agencies, including the interagency review draft are posted on this site.

URLs/Downloads:

Record Details:

Acronyms:

Document IDs: